What's strange is that although doctors have been reluctant to adopt AI like MYCIN, the pace of adoption for other innovations like new surgeries, drugs, and implantable devices is actually quite rapid. So I don't think doctors reject new methods in general.

I think the hidden factor here is the business model. A new surgery makes money for a hospital, which provides a countervailing force to the caution you mention.

A new diagnosis algorithm may lose the hospital money, so what is the force that is going to push for its adoption?